Citations

Showing 10 of 108162 citations.

P3‐058: PARTIAL INHIBITION OF MITOCHONDRIAL COMPLEX I ENHANCES MITOCHONDRIAL BIOENERGETICS VIA OXIDATIVE PHOSPHORYLATION SUPER‐COMPLEX REARRANGEMENT: IMPLICATION FOR ALZHEIMER'S DISEASE
Flannery, Padraig J., Trushin, Sergey , Trushina, Eugenia , Stojakovic, Andrea

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_18 | Pages: No page available

10.1016/j.jalz.2019.06.3085 Get It

P3‐017: ELECTROCONVULSIVE THERAPY FOR THE TREATMENT OF ACUTE AGITATION AND AGGRESSION IN ALZHEIMER'S DEMENTIA (ECT‐AD)
Forester, Brent P. , Mathias, Liana, Monette, Patrick , Rahman, Aniqa, Harper, David G. , Seiner, Stephen J., Knapp, Rebecca G. , Hermida, Adriana P., Nykamp, Louis, Petrides, Georgios, Mellen, Emily , Mueller, Martina , Lapid, Maria I.

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_18 | Pages: No page available

10.1016/j.jalz.2019.06.3043 Get It

Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603)
Leon‐Ferre, Roberto A. , Novotny, Paul J. , Wolfe, Eric, Ruddy, Kathryn J. , Flora, Daniel , Dakhil, Christopher, Rowland, Kendrith M. , Graham, Mark L., Le‐Lindqwister, Nguyet, Loprinzi, Charles L. , Wolfe, Eric G, Ruddy, Kathryn J , Smith, Thomas J , Faubion, Stephanie S. , Smith, Thomas J.

Mayo Clinic

JNCI Cancer Spectrum | October 18, 2019 | Volume: 4 | Issue: 1 | Pages: No page available

10.1093/jncics/pkz088 | PMID 32337497 Get It

Abstract Background Hot flashes (HFs) negatively affect quality of life among perimenopausal and postmenopausal women. This study investigated the efficacy of oxybutynin vs placebo in decreasing HFs. Methods In this randomized, multicenter, double-blind study, women with and without breast cancer with 28 or more HFs per week, lasting longer than 30 days, who were not candidates for estrogen-based therapy, were assigned to oral oxybutynin (2.5 mg twice a day or 5 mg twice a day) or placebo for 6 weeks. The primary endpoint was the intrapatient change from baseline in weekly HF score between each oxybutynin dose and placebo using a repeated-measures mixed model. Secondary endpoints included changes in weekly HF frequency, HF-related daily interference scale questionnaires, and self-reported symptoms. Results We enrolled 150 women. Baseline characteristics were well balanced. Mean (SD) age was 57 (8.2) years. Two-thirds (65%) were taking tamoxifen or an aromatase inhibitor. Patients on both oxybutynin doses reported greater reductions in the weekly HF score (5 mg twice a day: −16.9 [SD 15.6], 2.5 mg twice a day: −10.6 [SD 7.7]), placebo −5.7 (SD 10.2); P < .005 for both oxybutynin doses vs placebo), HF frequency (5 mg twice a day: −7.5 [SD 6.6], 2.5 mg twice a day: −4.8 [SD 3.2], placebo: −2.6 [SD 4.3]; P < .003 for both oxybutynin doses vs placebo), and improvement in most HF-related daily interference scale measures and in overall quality of life. Patients on both oxybutynin arms reported more side effects than patients on placebo, particularly dry mouth, difficulty urinating, and abdominal pain. Most side effects were grade 1 or 2. There were no differences in study discontinuation because of adverse effects. Conclusion Oxybutynin is an effective and relatively well-tolerated treatment option for women with HFs.
P2‐427: THE RELATIONSHIP BETWEEN HISPANIC ETHNICITY, AMYLOID LOAD AND APOE4 CARRIER STATUS
Duara, Ranjan , Lizarraga, Gabriel , Adjouadi, Malek , Barker, Warren , Greig‐Custo, Maria T., Rosselli, Mónica , Curiel, Rosie E. , Hanson, Kevin , Ertekin‐Taner, Nilüfer , Vaillancourt, David E. , Santi, Susan De , Golde, Todd E. , Duara, Ranjan , Loewenstein, David , Marsiske, Michael , DeKosky, Steven T.

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_15 | Pages: No page available

10.1016/j.jalz.2019.06.2834 Get It

P2‐397: GYRIFICATION ABNORMALITIES IN PRESYMPTOMATIC C9ORF72 EXPANSION CARRIERS
Lee, Suzee E. , Battistella, Giovanni , Chu, Stephanie A. , Rosen, Howard J. , Karydas, Anna M., Coppola, Giovanni , Geschwind, Daniel H. , Rademakers, Rosa , Tempini, Maria Luisa Gorno , Caverzasi, Eduardo , Zanto, Theodore P. , Miller, Bruce L. , Seeley, William W.

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_14 | Pages: No page available

10.1016/j.jalz.2019.06.2804 Get It

P2‐342: THE EFFECT OF RACE ON THE ASSOCIATION BETWEEN WHITE MATTER STRUCTURE AND BRAIN AMYLOID DEPOSITION: THE ARIC‐PET STUDY
Hughes, Timothy M. , Sharrett, Richey, Wong, Dean F. , Walker, Keenan A. , Zhou, Yun , Jack, Clifford R. , Knopman, David S. , Mosley, Thomas H. , Gottesman, Rebecca F.

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_14 | Pages: No page available

10.1016/j.jalz.2019.06.2749 Get It

P2‐332: ASSOCIATION BETWEEN VOLUME OF THE MEDIAL SEPTUM AND ALLOCENTRIC SPATIAL NAVIGATION IS MEDIATED BY HIPPOCAMPAL VOLUME
Lerch, Ondřej , Laczó, Jan , Pařízková, Martina, Nedelská, Zuzana , Hort, Jakub

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_14 | Pages: No page available

10.1016/j.jalz.2019.06.2739 Get It

P2‐329: TRACKING WHITE MATTER DEGENERATION IN ASYMPTOMATIC AND SYMPTOMATIC MAPT MUTATION CARRIERS WITH DTI
Tosakulwong, Nirubol , Lesnick, Timothy G. , Bove, Jessica, Brushaber, Danielle , Coppola, Giovanni , Dheel, Christina, Dickerson, Brad C., Dickinson, Susan, Faber, Kelley , Fields, Julie A. , Foroud, Tatiana M., Forsberg, Leah K. , Gavrilova, Ralitza H. , Gearhart, Debra, Ghoshal, Nupur , Graff‐Radford, Jonathan , Graff‐Radford, Neill R. , Haley, Dana , Heuer, Hilary W. , Huey, Edward D. , Jones, Lynne C. , Karydas, Anna M., Kornak, John , Kramer, Joel H. , Lucente, Diane , Lungu, Codrin , Mackenzie, Ian R. , Manoochehri, Masood , McGinnis, Scott, Pearlman, Rodney , Petrucelli, Leonard , Potter, Madeline, Rademakers, Rosa , Ramos, Eliana Marisa , Rankin, Katherine P. , Rascovsky, Katya, Sengdy, Pheth, Shaw, Leslie M. , Syrjanen, Jeremy A. , Tatton, Nadine , Taylor, Joanne, Toga, Arthur W. , Trojanowski, John Q. , Weıntraub, Sandra , Boxer, Adam L. , Rosen, Howard J. , Chen, Qin , Boeve, Bradley F. , Schwarz, Christopher G. , Reid, Robert I. , Brannelly, Patrick , Fong, Jamie , Goldman, Jill , Grossman, Murray , Hsiung, Ging‐Yuek Robin , Irwin, David J. , Jack, Clifford R. , Jones, David T. , Jones, Lynne, Knopman, David S. , Kremers, Walter K. , Kukull, Walter A. , Lapid, Maria I. , Miller, Bruce L. , Wong, Bonnie , Wszołek, Zbigniew K. , Kantarci, Kejal

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_14 | Pages: No page available

10.1016/j.jalz.2019.06.2736 Get It

P2‐314: THE MULTIDOMAIN IMPAIRMENT RATING (MIR) SCALE: INITIAL RELIABILITY DATA ON A MULTIDIMENSIONAL SCALE DESIGNED FOR FTLD SPECTRUM DISORDERS
Forsberg, Leah K. , Boxer, Adam L. , Rosen, Howard J. , Kornak, John , Heuer, Hilary W. , Fields, Julie A. , Brushaber, Danielle , Sturm, Virginia E. , Staffaroni, Adam M. , Ljubenkov, Peter A. , Denver, Reilly, Ong, Elise, Bordelon, Yvette , Coppola, Giovanni, Dickerson, Brad C., Dickinson, Susan, Faber, Kelley, Gavrilova, Ralitza H. , Gearhart, Debra, Ghoshal, Nupur , Graff‐Radford, Jonathan , Graff-Radford, N. R., Huey, Edward D. , Karydas, Anna M., Kaufer, Daniel , Kraft, Ruth, Kramer, Joel H. , Lucente, Diane , Lungu, Codrin , Mackenzie, Ian R. , McGinnis, Scott M., Mendez, Mario F. , Onyike, Chiadi U. , Pantelyat, Alex, Pearlman, Rodney , Petrucelli, Leonard , Potter, Madeline, Rademakers, Rosa , Ramos, Eliana Marisa , Rankin, Katherine P. , Rascovsky, Katya, Rogalskı, Emily , Shaw, Leslie M. , Sutherland, M. Anne, Syrjanen, Jeremy A. , Tatton, Nadine , Taylor, Joanne, Trojanowski, John Q. , Weıntraub, Sandra , Boeve, Bradley F. , Machulda, Mary M. , Appleby, Brian S. , Brannelly, Patrick , Coppola, Giovanni, Domoto‐Reilly, Kimiko , Fong, Jamie , Foroud, Tatiana , Goldman, Jill , Grossman, Murray , Hsiung, Ging‐Yuek Robin , Irwin, David J. , Jones, David T. , Kantarci, Kejal , Kerwin, Diana , Knopman, David S. , Kremers, Walter K. , Kukull, Walter A. , Litvan, Irene , Miller, Bruce L. , Roberson, Erik D. , Sutherland, Marg, Tartaglia, Maria Carmela , Toga, Arthur W. , Wong, Bonnie , Wszołek, Zbigniew K.

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_14 | Pages: No page available

10.1016/j.jalz.2019.06.2721 Get It